Corium International, Inc.

Corium International, Inc.

Corium International, Inc.

Overview
Date Founded

1999

Headquarters

235 Constitution Drive, Menlo Park, CA, 94025, USA

Type of Company

Public

Employees (Worldwide)

501 - 1,000

Industries

Pharmaceuticals
Holding Companies
Medical Products & Equipment
Hospitals & Patient Services
Biotechnology

Company Description

Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Contact Data
Trying to get in touch with decision makers at Corium International, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Chief Financial Officer

Chief Technology Officer & Vice President, Research & Development

Chief Medical Officer

Head of Corporate Strategy & Business Planning

Head of the CNS Business Unit

Head of Human Resources & Internal Communications

Ph.D., R.Ph., Head of Regulatory & Quality Assurance

Head of Market Access, Supply Chain & Project Management

Benefit Plan Administrator

Board of Directors

Senior Partner at Gurnet Point Capital LLC

Former Chief Financial Officer at Atlas Venture, Inc.

President, Chief Executive Officer & Director at Corium International, Inc.

Partner at Gurnet Point Capital LLC

Partner at Gurnet Point Capital LLC

Paths to Corium International, Inc.
Potential Connections via
Relationship Science
You
Corium International, Inc.
Recent Transactions
Details Hidden

Gurnet Point Capital LLC purchases Corium International, Inc.

Details Hidden

Corium International, Inc. issued USD Common Stock

Details Hidden

Corium International, Inc. issued USD Common Stock

Transaction Advisors
Escrow Agent

Advised onCorium International, Inc. issued USD Common Stock

Auditor

Advised onCorium International, Inc. issued USD Common Stock

Underwriter

Advised onCorium International, Inc. issued USD Common Stock

Co-Chair, Securities & Corporate Finance Practice

Advised onGurnet Point Capital LLC purchases Corium International, Inc.

Legal Advisor

Advised onCorium International, Inc. issued USD Common Stock

Associate

Advised onCorium International, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Co-Chair, Securities & Corporate Finance Practice at Fenwick & West LLP

Legal Advisor

Partner at Fenwick & West LLP

Legal Advisor

Of Counsel at Fenwick & West LLP

Clients

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment comprises of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home Care segment consist of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty brands segments includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment offers manufacturing and selling of branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

Key Stats and Financials As of
Market Capitalization
$463M
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
Investors
Details Hidden

Professional at Corium International, Inc.

Details Hidden

Co-Founder at Corium International, Inc.

Details Hidden

Gurnet Point Capital invests in companies located in the US. The firm targets companies operating in the fields of life sciences and medical technologies. It provides financing for buyout and all stages of product development and acquires majority stake in the company.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Walgreens Boots Alliance, Inc. Retail: Drug Stores - Deerfield, IL

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services. The Retail Pharmacy International segment consists of pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of the Alliance Healthcare pharmaceutical wholesaling and distribution businesses and an equity method investment in AmerisourceBergen. The company was founded in 1901 and is headquartered in Deerfield, IL.

CVS Health Corp. Retail: Drug Stores - Woonsocket, RI

CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Corium International, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Corium International, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Corium International, Inc..